Pharmacotherapy in Diabetes Management

Join our Continuing Education (CE) course designed specifically for Nurses and Nurse Practitioners (NPs) on Pharmacotherapy in Diabetes Management to gain a comprehensive understanding of diabetes care and medication protocols. This in-depth course examines the various types of diabetes, including Type 1, Type 2, and gestational diabetes, as well as their diagnostic criteria and clinical implications. It provides an overview of current pharmacological treatments, including insulin preparations, oral hypoglycemics, GLP-1 receptor agonists, and synthetic amylin analogs. Emphasis is placed on individualized treatment plans that consider patient-specific factors such as age, comorbidities, lifestyle, and risk of complications. In addition to medication knowledge, the course includes best practices in patient education, focusing on enhancing adherence, correct medication administration, and recognizing the symptoms and management of hypoglycemia and hyperglycemia. Nurses and NPs will benefit from practical tools and case-based insights to support informed decision-making and improve outcomes for patients with diabetes. The course supports high-quality, safe, and effective care in both primary and specialty clinical settings. Enroll today to advance your professional expertise in one of the most critical areas of chronic disease management.

Educational Objectives

• Differentiate between major types of diabetes (Type 1, Type 2, and gestational) and apply the respective diagnostic criteria.
• Describe the pharmacodynamics, indications, and adverse effects of insulin therapies and insulin analogs.
• Examine the mechanisms and clinical utility of oral hypoglycemics, GLP-1 receptor agonists, and other non-insulin pharmacotherapies.
• Develop patient-centered diabetes treatment strategies tailored to clinical context and patient-specific factors.
• Strengthen patient education efforts, emphasizing safe medication administration and recognition of hypo- and hyperglycemia.

Who Should Do This Course

This course is designed for Registered Nurses (RNs) and Nurse Practitioners (NPs) who manage patients with diabetes in primary care, endocrinology, internal medicine, and community health settings. It fulfills state-mandated requirements for license renewal related to pharmacology for the following states:

• Advanced Pharmacology – Nursing: Ohio, Alaska
• Pharmacotherapeutics – Nursing: Hawaii, Louisiana, Oklahoma, West Virginia, Connecticut, Arkansas, Illinois, Nebraska, South Carolina, Texas, Washington, Wisconsin
• Pharmacology – Nursing: Alabama, Indiana

Did You Know?

• As of 2022, over 37.3 million Americans—about 11.3% of the U.S. population—have diabetes (CDC).
• Diabetes is the 8th leading cause of death in the United States (CDC, 2022).
• Effective pharmacologic interventions can reduce diabetes complications by up to 76% (ADA).
• GLP-1 receptor agonists not only control glucose levels but also support weight loss and cardiovascular benefits.
• Medication adherence in diabetic patients improves outcomes and lowers long-term healthcare costs significantly.